Skip to content

Acupuncture for rheumatoid arthritis (RA): Protocol for a Real-World Study

Acupuncture for rheumatoid arthritis (RA): Protocol for a Real-World Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075439
Enrollment
Unknown
Registered
2023-09-05
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

JC (essential treatment) groups:Oral methotrexate of 10mg-15mg/week, and oral folic acid of 5mg/week (taken on the second day of methotrexate). Addition celecoxib capsules if the pain is significant (
ZJ (acupuncture and essential treatment):Acupuncture will add to the primary care and essential western medical treatment. The patient will be prone, and the following acupoints will select according

Sponsors

Traditional Chinese Medicine Hospital of Dianjiang Chongqing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Those aged between 45 and 85 years and who can clearly express their medical condition 2) Those who meet the diagnostic criteria for RA in Western medicine 3) Those who meet the diagnostic criteria for TCM 4) Those who had not received other interventions, such as acupuncture and moxibustion or cupping within two months 5) Those who voluntarily participated in this study signed the informed consent form and were able to follow up.

Exclusion criteria

Exclusion criteria: 1) Patients who are prone to needle sickness. 2) Patients with a combination of primary severe diseases, such as cardiovascular, cerebrovascular, renal, and hematopoietic diseases and psychiatric disorders. 3) Patients with severe chronic infections, current infections, and malignancies. 4) Patients with overlapping other immune diseases, such as systemic lupus erythematosus and dry syndrome 5) Patients with severe joint deformities and loss of joint mobility that prevents scoring 6) Women who are currently pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
DAS28 scores;VAS scores;ESR;CRP;TCM evidence scores;

Secondary

MeasureTime frame
Time to morning stiffness;HAQ scores;

Countries

China

Contacts

Public ContactTianxin Yi

Traditional Chinese Medicine Hospital of Dianjiang Chongqing

xiaotianxin998@163.com+86 183 2397 2252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026